Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study

被引：0
|
作者：
Bista, Amir
Shafii, Bahman
Shah, Binay K.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1747.1747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1747
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hexokinase II Expression As a Prognosis Marker in Diffuse Large B-Cell Lymphoma (DLBCL) Pre- and Post- the Incorporation of Rituximab to Standard CHOP Chemotherapy
    Gu, Juan J.
    Liu, Yizhen
    Jin, Jia
    Yang, Ling
    Xia, Zuguang
    Liu, Xiaojian
    Lv, Fangfang
    Hernandez-Ilizaliturri, Francisco J.
    Hong, Xiaonan
    Cao, Junning
    Zhang, Qunling
    BLOOD, 2019, 134
  • [42] Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival
    Huijie Zhou
    Qiuluo Liu
    Siyan Lu
    Liqun Zou
    Annals of Hematology, 2023, 102 : 1879 - 1886
  • [43] Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival
    Zhou, Huijie
    Liu, Qiuluo
    Lu, Siyan
    Zou, Liqun
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1879 - 1886
  • [44] The impact of race, age, and sex in follicular lymphoma (FL): A comprehensive SEER analysis in the pre- and post-rituximab (R) eras.
    Nabhan, Chadi
    Aschebrook-Kilfoy, Briseis
    Chiu, Brian C-H
    Kruczek, Kimberly R.
    Clemenzi-Allen, Angelo
    Patel, Anand
    Smith, Sonali M.
    Evens, Andrew M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study
    Hang, Haifang
    Zhou, Hui
    Ma, Liyuan
    MEDICINE, 2024, 103 (08) : E37238
  • [46] Impact of Rituximab and Methotrexate on the Survival of the Patients with Sinonasal Tract Diffuse Large B-Cell Lymphoma
    Vahamurto, Pauli
    Mannisto, Susanna
    Pollari, Marjukka
    Karjalainen-Lindsberg, Marja-Liisa
    Makitie, Antti A.
    Leppa, Sirpa
    BLOOD, 2016, 128 (22)
  • [47] Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis
    Valcarcel, Bryan
    Schonfeld, Sara J.
    Shiels, Meredith S.
    Castillo, Jorge J.
    Morton, Lindsay M.
    HAEMATOLOGICA, 2025, 110 (03) : 799 - 803
  • [48] Improved Survival with Rituximab-Based Chemoimmunotherapy in Patients with Primary Testicular Diffuse Large B-Cell Lymphoma
    He, Shengli
    Chen, Menghao
    Miao, Yi
    BLOOD, 2023, 142
  • [49] Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
    Olszewski, Adam J.
    Winer, Eric S.
    Castillo, Jorge J.
    LEUKEMIA RESEARCH, 2014, 38 (08) : 866 - 873
  • [50] Prognostic Significance of Interim 18f-FDG PET/CT for the Treatment of Diffuse Large B-Cell Lymphoma In the Post-Rituximab Era.
    Yang, Deok-Hwan
    Min, Jung-Joon
    Song, Ho-Chun
    Jeong, Yong Yeon
    Chung, Woong-Ki
    Bae, Soo-Young
    Ahn, Jae-Sook
    Kim, Yeo-Kyeoung
    Bom, Hee-Seung
    Chung, Ik-Joo
    Kim, Hyeoung Joon
    Lee, Je-Jung
    BLOOD, 2010, 116 (21) : 751 - 752
12345